StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.43+0.01 (+0.70%)

Close on Nov 18, 2026Market cap $53.52MP/E –Yield –

Tenax Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Tenax Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0. The highest annual figure on record is $1.19M in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0-100.0%
FY2015Apr 30, 2015$49.29K-69.0%
FY2014Apr 30, 2014$158.93K-86.7%
FY2013Apr 30, 2013$1.19M+227.4%
FY2012Apr 30, 2012$363.78K+252.6%
FY2011Apr 30, 2011$103.17K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$0–
Q1 FY2026CQ1 2026Mar 31, 2026$0–
Q4 FY2025CQ4 2025Dec 31, 2025$0-100.0%
Q3 FY2025CQ3 2025Sep 30, 2025$0–
Q2 FY2025CQ2 2025Jun 30, 2025$0–
Q1 FY2025CQ1 2025Mar 31, 2025$0–
Q4 FY2015CQ1 2015Apr 30, 2015$49.29K–
Q3 FY2015CQ4 2014Jan 31, 2015$0–

More Tenax Therapeutics figures

See a number that looks wrong?